Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Sandström

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Vaccine|August 7, 2012
Epstein-Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infectionAnna M C Friis, Börje Akerlund, Katarina Gyllensten, et al.
Antiviral Therapy|February 17, 2007
HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual menAnna Lindström, Anna Ohlis, Marleen Huigen, et al.
BMC Public Health|June 1, 2010
Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, TanzaniaEdith A M Tarimo, Anna Thorson, Thecla W Kohi, et al.
Scandinavian Journal of Infectious Diseases|March 28, 2006
Antiretroviral treatment of HIV infection: Swedish recommendations 2005Magnus Gisslén, Jane Ahlqvist-Rastad, Jan Albert, et al.
Vaccine|April 8, 2004
Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV)Ann-Charlotte Boström, Bo Hejdeman, Reikei Matsuda, et al.
Clinical and Vaccine Immunology : CVI|May 14, 2010
Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genesSaid Aboud, Charlotta Nilsson, Katarina Karlén, et al.
Vaccine|May 6, 2008
Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunizationLindvi Gudmundsdotter, Ann-Charlotte Boström, Catherine Burton, et al.
Human Vaccines & Immunotherapeutics|August 6, 2013
Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsivenessSalma Nowroozalizadeh, Lindvi Gudmundsdotter, Bo Hejdeman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 20, 2022
The Prevalence, Incidence, and Risk Factors for HIV Among Female Sex Workers-A Cohort Being Prepared for a Phase IIb HIV Vaccine Trial in Dar es Salaam, TanzaniaDiana Faini, Frank Msafiri, Patricia Munseri, et al.
Microbiology and Immunology|August 23, 2006
Human immunodeficiency virus-type 1 specific cellular immunity in chronic infected patients on prolonged highly active antiretroviral treatment and on structured treatment interruptionReikei Matsuda, Ann-Charlotte Boström, Malin Fredriksson, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Vaccine|August 7, 2012
Epstein-Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infectionAnna M C Friis, Börje Akerlund, Katarina Gyllensten, et al.
Antiviral Therapy|February 17, 2007
HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual menAnna Lindström, Anna Ohlis, Marleen Huigen, et al.
BMC Public Health|June 1, 2010
Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, TanzaniaEdith A M Tarimo, Anna Thorson, Thecla W Kohi, et al.
Scandinavian Journal of Infectious Diseases|March 28, 2006
Antiretroviral treatment of HIV infection: Swedish recommendations 2005Magnus Gisslén, Jane Ahlqvist-Rastad, Jan Albert, et al.
Vaccine|April 8, 2004
Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV)Ann-Charlotte Boström, Bo Hejdeman, Reikei Matsuda, et al.
Clinical and Vaccine Immunology : CVI|May 14, 2010
Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genesSaid Aboud, Charlotta Nilsson, Katarina Karlén, et al.
Vaccine|May 6, 2008
Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunizationLindvi Gudmundsdotter, Ann-Charlotte Boström, Catherine Burton, et al.
Human Vaccines & Immunotherapeutics|August 6, 2013
Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsivenessSalma Nowroozalizadeh, Lindvi Gudmundsdotter, Bo Hejdeman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 20, 2022
The Prevalence, Incidence, and Risk Factors for HIV Among Female Sex Workers-A Cohort Being Prepared for a Phase IIb HIV Vaccine Trial in Dar es Salaam, TanzaniaDiana Faini, Frank Msafiri, Patricia Munseri, et al.
Microbiology and Immunology|August 23, 2006
Human immunodeficiency virus-type 1 specific cellular immunity in chronic infected patients on prolonged highly active antiretroviral treatment and on structured treatment interruptionReikei Matsuda, Ann-Charlotte Boström, Malin Fredriksson, et al.
Pageof 6